Under the license and distribution agreement, Roche will sell Exiqon's ProbeLibrary products, which are compatible with over 17,000 installed RT-PCR detection instruments, according to Exiqon. The companies did not disclose financial details of the deal.
Roche said the new products will help it complete its high-throughput product portfolio. The company also plans to launch a new instrument, called LightCycler 480, in the second half of the year. Exiqon's ProbeLibrary was launched a year ago and allows users to design over 2.5 million RT-PCR assays in seven organisms.